# US 2023/0149171 A1 · Expandable implantable conduit

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0149171 A1
- Document ID: US20230149171A1
- Status: Published application
- Kind: A1
- Application number: 18/157,709
- Filed: 2023-01-20
- Published: 2023-05-18
- Earliest claimed: 2013-03-08
- Assignees: Carnegie Mellon University
- Applicants: Carnegie Mellon University
- Inventors: C. Douglas BERNSTEIN; Arush KALRA
- Web page: https://patentgrep.com/patent/US20230149171A1

## CPC

- A61F 2/2475: {Venous valves}
- A61F 2/2412: {with soft flexible valve members, e.g. tissue valves shaped like natural valves}
- A61F 2/2418: {Scaffolds therefor, e.g. support stents}
- G05B 19/4099: Surface or curve machining, making three-dimensional [3D] objects, e.g. desktop manufacturing
- A61F 2/2415: {Manufacturing methods}
- A61F 2002/30706: {specially designed for children, e.g. having means for adjusting to their growth}
- A61F 2210/0004: bioabsorbable
- A61F 2220/0075: sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
- A61F 2250/0007: for adjusting length
- A61F 2250/006: modular
- A61F 2250/0082: specially designed for children, e.g. having means for adjusting to their growth
- G05B 2219/42155: Model
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- G05B: CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS (systems for controlling or regulating non-electric variables G05D; systems for regulating electric or magnetic variables G05F; control devices or systems insofar as characterised by mechanical features only G05G)

## Abstract

An expandable valved conduit for pediatric right ventricular outflow tract (RVOT) reconstruction is disclosed. The valved conduit may provide long-term patency and resistance to thrombosis and stenosis. The valved conduit may enlarge radially and/or longitudinally to accommodate the growing anatomy of the patient. Further, a method is disclosed for the manufacture of the valved conduit based in part on a plastically deformable biocompatible polymer and a computer-optimized valve design developed for such an expandable valved conduit.

## Claims

### Claim 1

An implantable device for implantation into a human or animal, the implantable device comprising:
a fluoropolymer conduit having an inner layer and an outer layer;
wherein the fluoropolymer conduit has a radial expandability in a range from 20% to 200% above an initial conduit radius,
wherein the outer layer has a yield strength of about 0.05 MPa to about 4 MPa, and wherein the outer layer has an ultimate tensile strength of greater than about 4 MPa.

### Claim 2 (depends on 1)

The implantable device of claim 1, wherein the outer layer has a wall thickness of about 0.2 mm to about 2.0 mm.

### Claim 3 (depends on 1)

The implantable device of claim 1, wherein the outer layer has a density of about 0.2 mg/mm3 to about 0.8 mg/mm3.

### Claim 4 (depends on 1)

The implantable device of claim 1, wherein the inner layer has a density of about 1.0 mg/mm3 to about 2 mg/mm3.

### Claim 5 (depends on 1)

The implantable device of claim 1, wherein the fluoropolymer conduit is configured to be implanted into a cardiovascular structure using sutures, and wherein the fluoropolymer conduit has a suture retention strength greater than or about equal to 0.5 N.

### Claim 6 (depends on 1)

The implantable device of claim 1, wherein the fluoropolymer conduit further comprises a valve structure.

### Claim 7 (depends on 1)

The implantable device of claim 1, wherein the fluoropolymer conduit comprises nodes having an internode distance of about 10 microns to about 40 microns.

### Claim 8

A valved conduit for implantation into a human or animal, the valved conduit comprising:
a fluoropolymer conduit having an initial radius, the fluoropolymer conduit configured to be expanded from an unexpanded state to an expanded state; and
a valve structure disposed within the fluoropolymer conduit, the valve structure comprising two leaflets and having a closed state and an open state;
wherein the fluoropolymer conduit has a radial expandability in a range from 20% to 200% above the initial radius,
wherein the fluoropolymer conduit has a yield strength of about 0.05 MPa to about 4 MPa and an ultimate tensile strength of greater than about 4 MPa,
wherein, when the fluoropolymer conduit is in the unexpanded state and the valve structure is in the closed state, the leaflets overlap, and
wherein, when the fluoropolymer conduit is in the expanded state and the valve structure is in the closed state, the leaflets do not overlap.

### Claim 9 (depends on 8)

The valved conduit of claim 8, wherein the valve structure comprises three leaflets.

### Claim 10 (depends on 8)

The valved conduit of claim 8, wherein the leaflets are at least partially domed in the unexpanded state.

### Claim 11 (depends on 8)

The valved conduit of claim 8, wherein the valved conduit has a regurgitation fraction less than or equal to about 30%.

### Claim 12 (depends on 8)

The valved conduit of claim 8, wherein the fluoropolymer conduit comprises nodes having an internode distance of about 10 microns to about 40 microns.

### Claim 13

A valved conduit for implantation into a human or animal, the valved conduit consisting of:
a fluoropolymer conduit having radial expandability in a range from 20% to 200% above an initial conduit radius; and
a valve structure disposed therein;
wherein the fluoropolymer conduit has a yield strength of about 0.05 MPa to about 4 MPa, and
wherein the fluoropolymer conduit has a suture retention strength greater than or about equal to 0.5 N.

### Claim 14 (depends on 13)

The valved conduit of claim 13, wherein the fluoropolymer conduit comprises a first conduit layer and a second conduit layer, and wherein the second conduit layer comprises a stent.

### Claim 15 (depends on 13)

The valved conduit of claim 13, wherein the valve structure comprises from one leaflet to three leaflets.

### Claim 16 (depends on 13)

The valved conduit of claim 13, wherein the valved conduit is configured to be implanted into a vascular structure using sutures, and wherein the valved conduit has a suture retention strength greater than or about equal to 0.8 N.

### Claim 17

An implantable device for implantation into a human or animal, the implantable device consisting of:
a fluoropolymer conduit having radial expandability in a range from 20% to 200% above an initial conduit radius, wherein the fluoropolymer conduit has a yield strength from about 0.05 MPa to about 4 MPa, and
wherein the fluoropolymer conduit has a suture retention strength greater than or about equal to 0.5 N.

### Claim 18 (depends on 17)

The implantable device of claim 17, wherein the implantable device is configured to be implanted into a cardiovascular structure using sutures, and wherein the fluoropolymer conduit has a suture retention strength greater than or about equal to 0.8 N.
